Title : Cardiac safety in clinical trials of phosphodiesterase 5 inhibitors.

Pub. Date : 2005 Dec 26

PMID : 16387565






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Since the introduction of the first PDE5 inhibitor, sildenafil, in 1998, there has been concern about the effects of these agents on the heart and their safety in patients with cardiovascular disease. Sildenafil Citrate phosphodiesterase 5A Homo sapiens